Login / Signup

Impact of 18F-FDG-PET/CT on Clinical Management in Patients with Cholangiocellular Carcinoma.

Lena Sophie KieferJulia SeklerBrigitte GückelMareen Sarah KrausChristian la FougèreKonstantin NikolaouMichael BitzerSergios GatidisChristina Pfannenberg
Published in: BJR open (2021)
Systematic implementation of 18F-FDG-PET/CT may enable a more appropriate and tailored treatment of patients with CCA, especially in cases of suspected recurrence.
Keyphrases
  • primary care
  • healthcare
  • pulmonary embolism
  • quality improvement